Specification Strength/ Size Packing Size Packed In HCV Test Cards 10 Card Test Per Pack 50 Box Pack
Specification Strength/ Size Packing Size Packed In Dengue Test 50 Card Test Per Pack 10 Box Pack
Specification Strength/ Size Packing Size Packed In Glucose Test Bottle of 100T
Specification Strength/ Size Packing Size Packed In Protein Test Bottle of 100T
Specification Strength/ Size Packing Size Packed In Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes Bottle of 100T
Molecular Diagnostic Tests for SARS-CoV-2 Other Tests for SARS-CoV-2 Serology and Other Adaptive Immune Response Tests for SARS-CoV-2 IVDs for Management of COVID-19 Patients
RNA Extraction Kit
Dengue Combo
Malaria Antigen Kit
Pap Smear Kit
HBS AG
HCV Test Kit
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2 [Product Approval] U.S FDA EUA, Health Canada IO, CE-IVD marked The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
A pregnancy test can confirm if a woman is pregnant. The test can be carried out at home or in the doctor's office. A pregnancy test is around 99 percent reliable. It works by measuring levels of a hormone called human chorionic gonadotropin (HCG). Categories - OTC - Over The Counter Product
I-can is a test kit, which helps to detect pregnancy. Every woman is excited to know whether she has conceived or not. This I- can kit will help you to confirm pregnancy. I-can detects pregnancy in five minutes. It confirms pregnancy by detecting the presence of human chorionic gonadotropin hormone (pregnancy hormone) in the urine. It gives an accurate estimation of pregnancy. Major benefit of this kit is that it is very simple to use and you do not require any assistance to determine pregnancy by using this kit.
Products - Human Chorionic Gonadotropin (HCG) Test Midstream (Colloidal Gold Immunochromatographic Assay) Product Description - Sensitivity: 25 mIU/ml Accuracy: > 99.5% ISO13485 & CE approved INTENDED USE Easy-Sweet hCG Test Midstream is an in vitro diagnostic (IVD) qualitative test for rapid detection of hCG in urine. This test is designed for self-testing use only. PRINCIPLE Easy-Sweet. hCG Midstream is two-side sandwich immunoassay for the qualitative determination of human chorionic gonadotropin (hCG) in urine. The membrane was precoated with anti alpha hCG capture antibodies on the test band region and goat anti mouse on the control band region. During the test, the urine specimen is allowed to react with anti beta hCG monoclonal antibody-colloid gold conjugate, which was predried on the test Midstream. The mixture then moves forward on the membrane by the capillary action. For a positive specimen, the conjugate binds to the hCG forming an antibody-antigen complex. This complex is captured by anti alpha hCG antibody on the test region to produces a visual pink color band when hCG concentration in specimen is equal to or greater than 25 mIU/ml. Regardless of the presence of hCG, as the mixture continues to move across the membrane to the control band region, the complex is captured by immobilized goat anti mouse antibodies to form a distinct pink colored control band. The presence of the control band indicated: 1) a normal flow is obtained, 2) antibody pre-coated on control line and colloidal gold conjugate are functional. 1 pc/individual pouch , 500pcs/ctn or customized
General Information One-Step Chlamydia Rapid Test (Swab/Urine) is detection of Chlamydia trachomatis in female cervical swab, male urethral swab and male urine specimens to aid in the diagnosis of Chlamydia infection. Detection limit:1*103IFU/ml Specimen: Swab/Urine Reading Time : 10min
General Information The Urinalysis Reagent Strips (Urine) are firm plastic strips onto which several separate reagent areas are affixed. The test is for the detection of one or more of the following analytes in urine: Ascorbic acid, Glucose, Bilirubin, Ketone (Acetoacetic acid), Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite , Leukocytes and so on.
General Information Method: Double Antigens Sandwich Method Sensitivity : 99.5% Specificity : 98.8% Specimen : Serum / Plasma Reading Time : 5- 10 min
The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples. HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.
